Literature DB >> 2917595

Effect of carteolol on renal function in healthy subjects and patients with hypertension.

K Tabei1, H Furuya, Y Asano, S Hosoda.   

Abstract

The effect of short- and long-term administration of carteolol on renal function has been examined in healthy subjects and in hypertensive patients with or without renal failure. In healthy subjects neither a single dose of 10 mg carteolol nor continuous administration of 20 mg/day for 7 days had any effect on creatinine clearance and renal blood flow. In all subjects the clearance rate of carteolol was about 400 ml/min and its fractional excretion of carteolol exceeded 300%, suggesting that the drug is secreted actively from renal tubules. Twenty-three hypertensive patients with or without renal dysfunction were given carteolol 10 to 20 mg/day for more than 50 weeks in addition to their standard antihypertensive regimens, which were left changed. Laboratory results were compared with the mean values of 50 weeks before and after the addition of carteolol, and none, including plasma creatinine, blood urea nitrogen and electrolytes, were significantly changed. Neither the estimated glomerular filtration rate nor the effect of the drug on blood pressure changed significantly during this prolonged treatment. It is concluded that carteolol had no effect on renal function in healthy subjects and in hypertensive patients with or without renal failure.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2917595     DOI: 10.1007/BF00561030

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  4 in total

1.  Pharmacokinetics and absolute bioavailability of carteolol, a new beta-adrenergic receptor blocking agent.

Authors:  T Ishizaki; A Ohnishi; T Sasaki; K Kushida; Y Horai; K Chiba; T Suganuma
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

2.  Renal effects of beta-adrenoceptor blockade.

Authors:  M A Weber; J I Drayer
Journal:  Kidney Int       Date:  1980-11       Impact factor: 10.612

3.  A simple method of estimating progression of chronic renal failure.

Authors:  W E Mitch; M Walser; G A Buffington; J Lemann
Journal:  Lancet       Date:  1976-12-18       Impact factor: 79.321

4.  [The determination of carteolol in human plasma and urine by high performance liquid chromatography].

Authors:  M Odomi; H Akiyama; K Matsuura; T Shimizu
Journal:  Yakugaku Zasshi       Date:  1985-05       Impact factor: 0.302

  4 in total
  2 in total

1.  Comparison of the renal effects of dilevalol and carteolol in patients with mild to moderate essential hypertension.

Authors:  T Baba; S Murabayashi; T Tomiyama; K Takebe
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Pharmacokinetics of carteolol in patients with impaired renal function.

Authors:  M Amemiya; K Tabei; H Furuya; Y Sakairi; Y Asano
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.